有効性試験市場は、予測期間、すなわち2020-30年の間、10.84％のCAGRで成長し、2020年の2億6,387万ドルから2030年までに5億9,405万ドルを超えると予想されます。
製品の安全性に対処する医薬品および化粧品の規制などが、今後数年間で有効性試験の世界市場の成長を促進する要因です。さらに、医薬品有効成分（API）の有効性が重要な懸念事項であり、市場は医薬品の規制と検証を検討しており、保存的有効性試験（PET）の多くの方法が、医薬品の登録に関する技術要件の調和に関する国際会議（ICH）や優れた臨床慣行（GCP）などの機関、業界団体、および個々の企業によって10年以上にわたって進歩してきました。これらの規制機関の主な目的は、優れた文書化基準と科学的健全性を満たすことです。.
目次
Contents
1. Executive Summary
2. Global Efficacy Testing Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8. Recent Development, Policies & Regulatory Landscape
9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. Global Efficacy Testing Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. Global Efficacy Testing Market
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12. Global Efficacy Testing: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada) By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America) By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe) By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific) By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa) By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Service Type: Market Share (2021-2030F)
12.2.1. Disinfectant Efficacy Testing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Antimicrobial/Preservative Efficacy Testing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By Application: Market Share (2021-2030F)
12.3.1. Consumer Product Applications, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. Medical Device Applications, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Pharmaceutical Manufacturing Applications, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.4. Cosmetics and Personal Care Product Applications, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
13. Company Profile
14. American Type Culture Collection (ATCC)
14.1. Company Overview
14.2. Company Total Revenue (Financials)
14.3. Market Potential
14.4. Global Presence
14.5. Key Performance Indicators
14.6. SWOT Analysis
14.7. Product Launch
15. bioMerieux SA
16. Charles River Laboratories International, Inc.
17. Eurofins Scientific
18. Becton
19. Dickinson and Company
20. Merck KgaA
21. North American Science Associates, Inc.
22. Pacific Biolabs
23. SGS SA
24. Toxikon Corporation
25. Wuxi Apptec Co., Ltd.
26. Other prominent players
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
